The present invention relates to compounds which inhibit, regulate and/or modulate
tyrosine kinase signal transduction, compositions which contain these compounds,
and methods of using them to treat tyrosine kinase-dependent diseases and conditions,
such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular
degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
